1,382
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Evolution of E. coli in a mouse model of inflammatory bowel disease leads to a disease-specific bacterial genotype and trade-offs with clinical relevance

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2286675 | Received 04 Sep 2023, Accepted 17 Nov 2023, Published online: 07 Dec 2023

References

  • Ott SJ, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53(5):685–18. doi:10.1136/gut.2003.025403.
  • Gevers D, Kugathasan S, Denson L, Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song S, Yassour M, et al. The treatment-naive microbiome in New-Onset Crohn’s disease. Cell Host & Microbe. 2014;15(3):382–392. doi:10.1016/j.chom.2014.02.005.
  • Rehman A, Rausch P, Wang J, Skieceviciene J, Kiudelis G, Bhagalia K, Amarapurkar D, Kupcinskas L, Schreiber S, Rosenstiel P, et al. Geographical patterns of the standing and active human gut microbiome in health and IBD. Gut. 2016;65(2):238–248. doi:10.1136/gutjnl-2014-308341.
  • Halfvarson J, Brislawn CJ, Lamendella R, Vázquez-Baeza Y, Walters WA, Bramer LM, D’Amato M, Bonfiglio F, McDonald D, Gonzalez A, et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat microbiol. 2017;2(5):17004. doi:10.1038/nmicrobiol.2017.4.
  • Schirmer M, Franzosa EA, Lloyd-Price J, McIver LJ, Schwager R, Poon TW, Ananthakrishnan AN, Andrews E, Barron G, Lake K, et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat microbiol. 2018;3(3):337–346. doi:10.1038/s41564-017-0089-z.
  • Schirmer M, Garner A, Vlamakis H, Xavier RJ. Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol. 2019;17(8):497–511. doi:10.1038/s41579-019-0213-6.
  • Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Järnerot G, Tysk C, Jansson JK, Engstrand L, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139(6):1844–1854.e1. doi:10.1053/j.gastro.2010.08.049.
  • Barreto HC, Gordo I. Intrahost evolution of the gut microbiota. Nat Rev Microbiol. 2023;21(9):590–603. doi:10.1038/s41579-023-00890-6.
  • Giraud A, Matic I, Tenaillon O, Clara A, Radman M, Fons M, Taddei F. Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Sci. 2001;291(5513):2606–2608. doi:10.1126/science.1056421.
  • Paepe MD, Gaboriau-Routhiau V, Rainteau D, Rakotobe S, Taddei F, Cerf-Bensussan N. Trade-off between bile resistance and nutritional competence drives Escherichia coli diversification in the mouse gut. PLoS Genet. 2011;7(6):e1002107. doi:10.1371/journal.pgen.1002107.
  • Barroso-Batista J, Sousa A, Lourenço M, Bergman M-L, Sobral D, Demengeot J, Xavier KB, Gordo I. The first steps of adaptation of Escherichia coli to the gut are dominated by soft sweeps. PLoS Genet. 2014;10(3):e1004182. doi:10.1371/journal.pgen.1004182.
  • Zhao S, Lieberman TD, Poyet M, Kauffman KM, Gibbons SM, Groussin M, Xavier RJ, Alm EJ. Adaptive evolution within gut microbiomes of healthy people. Cell Host & Microbe. 2019;25(5):656–667.e8. doi:10.1016/j.chom.2019.03.007.
  • Elhenawy W, Tsai CN, Coombes BK. Host-specific adaptive diversification of Crohn’s disease-associated adherent-invasive Escherichia coli. Cell Host & Microbe. 2019;25(2):301–312.e5. doi:10.1016/j.chom.2018.12.010.
  • Barreto HC, Sousa A, Gordo I. The landscape of adaptive evolution of a gut commensal bacteria in aging mice. Curr Biol. 2020;30(6):1102–1109.e5. doi:10.1016/j.cub.2020.01.037.
  • Daniel H. Diet and gut microbiome and the “chicken or egg” problem. Front Nutr. 2022;8:828630. doi:10.3389/fnut.2021.828630.
  • Garland T, Downs CJ, Ives AR. Trade-offs (and constraints) in Organismal Biology. Physiol Biochem Zool PBZ. 2022;95(1):82–112. doi:10.1086/717897.
  • Nesse RM, Ganten D, Gregory TR, Omenn GS. Evolutionary molecular medicine. J Mol Med Berl Ger. 2012;90(5):509–522. doi:10.1007/s00109-012-0889-9.
  • Merker M, Tueffers L, Vallier M, Groth EE, Sonnenkalb L, Unterweger D, Baines JF, Niemann S, Schulenburg H. Evolutionary approaches to combat antibiotic resistance: opportunities and challenges for precision Medicine. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.01938.
  • Roemhild R, Schulenburg H. Evolutionary ecology meets the antibiotic crisis: can we control pathogen adaptation through sequential therapy? Evol Med Public Health. 2019;2019(1):37–45. doi:10.1093/emph/eoz008.
  • Andersson DI, Balaban NQ, Baquero F, Courvalin P, Glaser P, Gophna U, Kishony R, Molin S, Tønjum T. Antibiotic resistance: turning evolutionary principles into clinical reality. FEMS Microbiol Rev. 2020;44(2):171–188. doi:10.1093/femsre/fuaa001.
  • Melnikov SV, Stevens DL, Fu X, Kwok HS, Zhang J-T, Shen Y, Sabina J, Lee K, Lee H, Söll D, et al. Exploiting evolutionary trade-offs for posttreatment management of drug-resistant populations. Proc Natl Acad Sci U S A. 2020;117(30):17924–17931. doi:10.1073/pnas.2003132117.
  • Hausser J, Szekely P, Bar N, Zimmer A, Sheftel H, Caldas C, Alon U. Tumor diversity and the trade-off between universal cancer tasks. Nat Commun. 2019;10(1):5423. doi:10.1038/s41467-019-13195-1.
  • Zhang J, Cunningham JJ, Brown JS, Gatenby RA. Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer. Nat Commun. 2017;8(1):1816. doi:10.1038/s41467-017-01968-5.
  • Jacqueline C, Biro PA, Beckmann C, Moller AP, Renaud F, Sorci G, Tasiemski A, Ujvari B, Thomas F. Cancer: a disease at the crossroads of trade‐offs. Evol Appl. 2016;10(3):215–225. doi:10.1111/eva.12444.
  • Cunningham JJ, Gatenby RA, Brown JS. Evolutionary dynamics in cancer therapy. Mol Pharm. 2011;8(6):2094–2100. doi:10.1021/mp2002279.
  • Kim SC, Tonkonogy SL, Karrasch T, Jobin C, Sartor RB. Dual-association of gnotobiotic il-10−/− mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm Bowel Dis. 2007;13(12):1457–1466. doi:10.1002/ibd.20246.
  • Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13(9):R79. doi:10.1186/gb-2012-13-9-r79.
  • Davenport M, Poles J, Leung JM, Wolff MJ, Abidi WM, Ullman T, Mayer L, Cho I, Loke P. Metabolic alterations to the mucosal microbiota in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(4):723–731. doi:10.1097/MIB.0000000000000011.
  • Brooun A, Tomashek JJ, Lewis K. Purification and Ligand binding of EmrR, a regulator of a multidrug transporter. J Bacteriol. 1999;181(16):5131–5133. doi:10.1128/JB.181.16.5131-5133.1999.
  • Coll JL, Heyde M, Portalier R. Expression of the nmpC gene of Escherichia coli K‐12 is modulated by external pH. Identification of cis ‐acting regulatory sequences involved in this regulation. Mol Microbiol. 1994;12(1):83–93. doi:10.1111/j.1365-2958.1994.tb00997.x.
  • Hirakawa H, Takumi-Kobayashi A, Theisen U, Hirata T, Nishino K, Yamaguchi A. AcrS/EnvR Represses Expression of the acrAB Multidrug Efflux Genes in Escherichia coli. J Bacteriol. 2008;190(18):6276–6279. doi:10.1128/JB.00190-08.
  • Heinken A, Hertel J, Acharya G, Ravcheev DA, Nyga M, Okpala OE, Hogan M, Magnúsdóttir S, Martinelli F, Nap B, et al. Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine. Nat Biotechnol. 2023;41(9):1320–1331. doi:10.1038/s41587-022-01628-0.
  • Huang Y-L, Chassard C, Hausmann M, von Itzstein M, Hennet T. Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice. Nat Commun. 2015;6(1):8141. doi:10.1038/ncomms9141.
  • Hofmann C, Dunger N, Schölmerich J, Falk W, Obermeier F. Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation. Inflamm Bowel Dis. 2010;16(11):1850–1858. doi:10.1002/ibd.21294.
  • Fernandes P. Fusidic acid: a bacterial elongation factor inhibitor for the oral treatment of acute and chronic staphylococcal infections. Cold Spring Harb Perspect Med. 2016;6(1):a025437. doi:10.1101/cshperspect.a025437.
  • Langholz E, Brynskov J, Bendtzen K, Vilien M, Binder V. Treatment of Crohn’s disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin. Aliment Pharmacol Ther. 2007;6(4):495–502. doi:10.1111/j.1365-2036.1992.tb00563.x.
  • Kilic FS, Erol K, Batu Ö, Yildirim E, Usluer G. The effects of fusidic acid on the inflammatory response in rats. Pharmacol Res. 2002;45(4):265–267. doi:10.1006/phrs.2001.0946.
  • Dapa T, Ramiro RS, Pedro MF, Gordo I, Xavier KB. Diet leaves a genetic signature in a keystone member of the gut microbiota. Cell Host & Microbe. 2022;30(2):183–199.e10. doi:10.1016/j.chom.2022.01.002.
  • Tawk C, Lim B, Bencivenga-Barry NA, Lees HJ, Ramos RJF, Cross J, Goodman AL. Infection leaves a genetic and functional mark on the gut population of a commensal bacterium. Cell Host & Microbe. 2023;31(5):811–826.e6. doi:10.1016/j.chom.2023.04.005.
  • Sakamoto A, Terui Y, Yoshida T, Yamamoto T, Suzuki H, Yamamoto K, Ishihama A, Igarashi K, Kashiwagi K. Three members of polyamine modulon under oxidative stress conditions: two transcription factors (SoxR and EmrR) and a Glutathione Synthetic Enzyme (GshA). PLoS ONE. 2015;10(4):e0124883. doi:10.1371/journal.pone.0124883.
  • Tian T, Wang Z, Zhang J. Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. Oxid Med Cell Longev. 2017;2017:4535194. doi:10.1155/2017/4535194.
  • Carmel-Harel O, Storz G. Roles of the glutathione- and thioredoxin-dependent reduction Systems in the Escherichia Coli and Saccharomyces Cerevisiae responses to oxidative stress. Annu Rev Microbiol. 2000;54(1):439–461. doi:10.1146/annurev.micro.54.1.439.
  • Łyżeń R, Gawron G, Kadziński L, Banecki B. GSH protects the Escherichia coli cells from high concentrations of thymoquinone. Molecules. 2022;27(8):2546. doi:10.3390/molecules27082546.
  • Pasternak BA, Dʼmello S, Jurickova II, Han X, Willson T, Flick L, Petiniot L, Uozumi N, Divanovic S, Traurnicht A, et al. Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohnʼs disease and murine colitis. Inflamm Bowel Dis. 2010;16(5):856–869. doi:10.1002/ibd.21132.
  • Jagt JZ, Struys EA, Ayada I, Bakkali A, Jansen EEW, Claesen J, van Limbergen JE, Benninga MA, de Boer NKH, de Meij TGJ, et al. Fecal amino acid analysis in newly diagnosed pediatric inflammatory bowel disease: a multicenter case-control study. Inflamm Bowel Dis. 2022;28(5):755–763. doi:10.1093/ibd/izab256.
  • Stacy A, Andrade-Oliveira V, McCulloch JA, Hild B, Oh JH, Perez-Chaparro PJ, Sim CK, Lim AI, Link VM, Enamorado M, et al. Infection trains the host for microbiota-enhanced resistance to pathogens. Cell. 2021;184(3):615–627.e17. doi:10.1016/j.cell.2020.12.011.
  • Son M, Ko JI, Kim WB, Kang HK, Kim BK. Taurine can ameliorate inflammatory bowel disease in rats. Adv Exp Med Biol. 1998;442:291–298.
  • Buret AG, Allain T, Motta J-P, Wallace JL. Effects of hydrogen sulfide on the microbiome: from toxicity to therapy. Antioxid Redox Signal. 2022;36(4–6):211–219. doi:10.1089/ars.2021.0004.
  • Maeda T, Wakasawa T, Shima Y, Tsuboi I, Aizawa S, Tamai I. Role of polyamines derived from arginine in differentiation and proliferation of human blood cells. Biol Pharm Bull. 2006;29(2):234–239. doi:10.1248/bpb.29.234.
  • Revilla-Nuin B, Reglero Á, Martı́nez-Blanco H, Bravo IG, Ferrero MA, Rodrı́guez-Aparicio LB. Transport of N-acetyl-D-mannosamine and N-acetyl-D-glucosamine in Escherichia coli K1: effect on capsular polysialic acid production. FEBS Lett. 2002;511(1–3):97–101. doi:10.1016/S0014-5793(01)03318-X.
  • Freland L, Beaulieu J-M. Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front Mol Neurosci. 2012;5:14. doi:10.3389/fnmol.2012.00014.
  • Inaba K, Kuroda T, Shimamoto T, Kayahara T, Tsuda M, Tsuchiya T. Lithium toxicity and Na+(Li+)/H+ antiporter in Escherichia coli. Biol Pharm Bull. 1994;17(3):395–398. doi:10.1248/bpb.17.395.
  • Chen CC, Tsuchiya T, Yamane Y, Wood JM, Wilson TH. Na+ (li+)-proline cotransport in Escherichia coli. J Membr Biol. 1985;84(2):157–164. doi:10.1007/BF01872213.
  • Gatenby RA, Brown JS. Integrating evolutionary dynamics into cancer therapy. Nat Rev Clin Oncol. 2020;17(11):675–686. doi:10.1038/s41571-020-0411-1.
  • Ezraty B, Barras F, Mignot T. The ‘liaisons dangereuses’ between iron and antibiotics. FEMS Microbiol Rev. 2016;40(3):418–435. doi:10.1093/femsre/fuw004.
  • Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: a comprehensive review. Front Med. 2021;8:765474. doi:10.3389/fmed.2021.765474.
  • Öhman L, Lasson A, Strömbeck A, Isaksson S, Hesselmar M, Simrén M, Strid H, Magnusson MK. Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis. Sci Rep. 2021;11(1):8641. doi:10.1038/s41598-021-87973-7.
  • Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, Huycke MM, Sartor RB. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology. 2005;128(4):891–906. doi:10.1053/j.gastro.2005.02.009.
  • Moolenbeek C, Ruitenberg EJ. The ‘Swiss roll’: a simple technique for histological studies of the rodent intestine. Lab Anim. 1981;15(1):57–60. doi:10.1258/002367781780958577.
  • Adolph TE, Tomczak MF, Niederreiter L, Ko H-J, Böck J, Martinez-Naves E, Glickman JN, Tschurtschenthaler M, Hartwig J, Hosomi S, et al. Paneth cells as a site of origin for intestinal inflammation. Nature. 2013;503(7475):272–276. doi:10.1038/nature12599.
  • Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17(1):10. doi:10.14806/ej.17.1.200.
  • KneadData – The Huttenhower Lab. https://huttenhower.sph.harvard.edu/kneaddata/.
  • Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–2120. doi:10.1093/bioinformatics/btu170.
  • Deatherage DE, Barrick JE. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. In: Sun L, and Shou W, editors. Engineering and analyzing multicellular systems. Vol. 1151. Springer New York: Humana Press; 2014. pp. 165–188.
  • Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8.
  • Kitamoto S, Alteri CJ, Rodrigues M, Nagao-Kitamoto H, Sugihara K, Himpsl SD, Bazzi M, Miyoshi M, Nishioka T, Hayashi A, et al. Dietary L-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gut. Nat microbiol. 2020;5(1):116–125. doi:10.1038/s41564-019-0591-6.
  • Haslauer KE, Schmitt-Kopplin P, Heinzmann SS. Data processing Optimization in untargeted metabolomics of urine using voigt lineshape model non-linear regression analysis. Metabolites. 2021;11(5):285. doi:10.3390/metabo11050285.
  • Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem. 2006;78(13):4281–4290. doi:10.1021/ac051632c.
  • Heinzmann SS, Waldenberger M, Peters A, Schmitt-Kopplin P. Cluster analysis Statistical spectroscopy for the Identification of metabolites in 1H NMR metabolomics. Metabolites. 2022;12(10):992. doi:10.3390/metabo12100992.
  • Csárdi G, Nepusz T. The igraph software package for complex network research. 2006.
  • R: A Language and Environment for Statistical Computing | BibSonomy. https://www.bibsonomy.org/bibtex/7469ffee3b07f9167cf47e7555041ee7.
  • Faust K, Croes D, van Helden J. Metabolic pathfinding using RPAIR annotation. J Mol Biol. 2009;388(2):390–414. doi:10.1016/j.jmb.2009.03.006.
  • Ebrahim A, Lerman JA, Palsson BO, Hyduke DR. Cobrapy: COnstraints-based reconstruction and analysis for python. BMC Syst Biol. 2013;7(1):74. doi:10.1186/1752-0509-7-74.
  • Anderson MJ. A new method for non-parametric multivariate analysis of variance. null. 2001;26(1):32–46. doi:10.1046/j.1442-9993.2001.01070.x.
  • Bray JR, Curtis JT. An ordination of the upland forest communities of Southern Wisconsin. Ecol Monogr. 1957;27(4):325–349. doi:10.2307/1942268.
  • Rohart F, Gautier B, Singh A, Cao K-AL, Schneidman D. mixOmics: an R package for ‘omics feature selection and multiple data integration. PLoS Comput Biol. 2017;13(11):e1005752. doi:https://doi.org/10.1371/journal.pcbi.1005752.
  • Signorell A . DescTools: Tools for Descriptive Statistics. 2023.